SOLUMEDROL 120 mg/2 ml, lyophilizate and solution for parenteral use bottle, 2 ml
Active ingredients: Methylprednisolone, Methylprednisolone hemisuccinate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Lyophilizate and solution for parenteral usebottle, 2 mlintramusculaire;intraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- SOLUMEDROL 120 mg/2 mL, lyophilisat et solution pour usage parentéral
- Pharmaceutical form
- lyophilisat et solution pour usage parentéral
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1978
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69774343CIP73155281CIP133400931552819Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHYLPREDNISOLONElyophilisat | 120,00 mg · un flacon | FT |
| MÉTHYLPREDNISOLONE (HÉMISUCCINATE DE)lyophilisat | 152,06 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.